Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Brightspire Capital Inc (NY: BRSP ) 5.885 -0.065 (-1.09%) Streaming Delayed Price Updated: 11:48 AM EDT, Sep 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Brightspire Capital Inc < Previous 1 2 Next > BRSP Stock Earnings: BrightSpire Capital Meets EPS, Beats Revenue for Q2 2024 July 30, 2024 BRSP stock results show that BrightSpire Capital met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. Via InvestorPlace BRSP Stock Earnings: BrightSpire Capital Beats EPS, Beats Revenue for Q1 2024 May 01, 2024 BRSP stock results show that BrightSpire Capital beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace GameStop Posts Downbeat Results, Joins Direct Digital, Forge Global And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session March 27, 2024 U.S. stock futures were higher this morning, with the Dow futures gaining by more than 100 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities Downgrades Flood In For Commercial Real Estate Stocks: Analysts Warn Of 'Rocky Road Ahead' March 04, 2024 Bank of America has downgraded six Commercial Real Estate mortgage REITs. Here's why. Via Benzinga Earnings Scheduled For February 21, 2024 February 21, 2024 Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million. Via Benzinga Earnings Preview For BrightSpire Capital February 20, 2024 Via Benzinga Earnings Outlook For BrightSpire Capital October 27, 2023 Via Benzinga Looking Into BrightSpire Capital's Return On Capital Employed May 09, 2023 Via Benzinga BrightSpire Capital: Q1 Earnings Insights May 03, 2023 Via Benzinga Looking Into BrightSpire Capital's Return On Capital Employed February 22, 2023 Via Benzinga US Mortgage Applications Surge As Rates Dip: Is The Industry Moving Out Of The Woods? Plus: Stocks, ETFs To Watch November 22, 2023 The latest data from the Mortgage Bankers Association (MBA) revealed a significant uptick in U.S. mortgage applications. Via Benzinga Topics ETFs These 3 REITs Just Jumped Higher On Earnings Beats November 02, 2023 Via Benzinga The Best-Performing Mortgage REITs In 2023 March 03, 2023 Among real estate investment trusts (REITs), one of the most popular subsectors with investors are mortgage REITs (mREITs). Although mREITs can be extremely volatile, their dividend yields are usually... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023 March 01, 2023 Via Benzinga Recap: BrightSpire Capital Q1 Earnings May 03, 2022 BrightSpire Capital (NYSE:BRSP) reported its Q1 earnings results on Tuesday, May 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Via Benzinga Earnings Scheduled For October 30, 2023 October 30, 2023 Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter. Via Benzinga Earnings Scheduled For February 22, 2022 February 22, 2022 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu... Via Benzinga Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 01, 2023 Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. Via Benzinga Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket March 01, 2023 Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday March 01, 2023 It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday! Via InvestorPlace Novavax, AMC Entertainment And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session March 01, 2023 U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga A Look Into Real Estate Sector Value Stocks January 16, 2023 Via Benzinga These 3 Mortgage REITs Have Yields Of Over 13% And Are Trading For Far Less Than They're Worth November 19, 2022 The VanEck Mortgage REIT Income ETF (ARCA: MORT) is down roughly 31% year-to-date, as a series of interest rate hikes by the Federal Reserve has sent a shock through real estate-related industries.... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 December 06, 2022 Via Benzinga BrightSpire Capital: Q3 Earnings Insights November 02, 2022 BrightSpire Capital (NYSE:BRSP) reported its Q3 earnings results on Wednesday, November 2, 2022 at 08:30 AM. Here's what investors need to know about the announcement. Earnings BrightSpire Capital... Via Benzinga BrightSpire Capital: Q2 Earnings Insights August 03, 2022 BrightSpire Capital (NYSE:BRSP) reported its Q2 earnings results on Wednesday, August 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Via Benzinga BrightSpire Capital's Return On Capital Employed Insights February 23, 2022 According to Benzinga Pro, during Q4, BrightSpire Capital (NYSE:BRSP) earned $83.26 million, a 216.15% increase from the preceding quarter. BrightSpire Capital also posted a total... Via Benzinga Recap: BrightSpire Capital Q4 Earnings February 22, 2022 BrightSpire Capital (NYSE:BRSP) reported its Q4 earnings results on Tuesday, February 22, 2022 at 08:00 AM. Here's what investors need to know about the announcement.... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022 February 18, 2022 Upgrades Roth Capital upgraded the previous rating for Denbury Inc (NYSE:DEN) from Neutral to Buy. For the third quarter, Denbury had an EPS of $0.74, compared to year-ago... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021 December 17, 2021 Upgrades According to Morgan Stanley, the prior rating for Definitive Healthcare Corp (NASDAQ: Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.